跳至主要内容
临床试验/NCT07196735
NCT07196735招募中不适用

Bio-electrical Impedance Analysis in Patients With Functional Dyspepsia

Universitair Ziekenhuis Brussel1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2025年9月18日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
40
试验地点
1
主要终点
Difference in phase angle between healthy patients and patients with FD

研究概览

简要总结

The primary objective of this study is to compare the BIA parameters, including Phase Angle, Fat Free Mass and Fat Mass, between women with functional dyspepsia and healthy women. All woman will undergo a bio-electrical impedance monitoring for this.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Women aged 18 - 75 years
  • Fulfilling the ROME IV criteria for functional dyspepsia (for FD patients)
  • FD unexplained by upper GI endoscopy during the past 12 months (mild gastritis allowed) (for FD patients).

排除标准

  • Clinical suspicion of an organic disorder different from FD (patients can be included when this disorder had been excluded);
  • Abnormality on upper GI endoscopy other than mild gastritis (for FD patients).
  • Known reflux oesophagitis Los Angeles grade C or D, known Barrett oesophagus, peptic stricture.
  • H pylori infection, unless treated at least 6 months before;
  • Known inflammatory bowel disorder;
  • Known major intestinal motility disorder;
  • Alcohol (defined as more than 14 U per week) or other substance abuse;
  • Active psychiatric disorder;
  • Known systemic or auto-immune disorder with implication for the GI system;
  • Prior abdominal surgery (with the exception of cholecystectomy or ap-pendectomy);
  • Any prior diagnosis of cancer other than basocellular carcinoma;
  • Current chemotherapy;
  • History of gastro-enteritis in the past 12 weeks;
  • Dietary supplements unless taken at a stable dose for more than 12 weeks;
  • Treatment with neuromodulators (one neuromodulator taken at a sta-ble dose for more than 12 weeks is allowed);
  • Treatment with PPI's during the past 8 weeks
  • Pregnancy.

结局指标

主要结局

Difference in phase angle between healthy patients and patients with FD

时间窗: from signing of the ICF till end of study (on average 1 week)

Difference in fat mass between healthy patients and patients with FD

时间窗: from signing of the ICF till end of study (on average 1 week)

Difference in fat free mass between healthy patients and patients with FD

时间窗: from signing of the ICF till end of study (on average 1 week)

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验